Clinical Trials Directory

Trials / Conditions / Neurocognitive Dysfunction

Neurocognitive Dysfunction

42 registered clinical trials studyying Neurocognitive Dysfunction10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNeurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Fu
NCT07408713
Rigshospitalet, Denmark
Not Yet RecruitingMonitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
NCT07140445
Rigshospitalet, Denmark
RecruitingRemotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
NCT06413173
United States Naval Medical Center, San DiegoN/A
RecruitingEarly Severe Illness TrAnslational BioLogy InformaticS in Humans
NCT05591924
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
CompletedNeuro-cognitive Function 1 Year Post ICU Discharge Among VV ECMO Survivors
NCT06224088
Meir Medical Center
RecruitingEvaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI
NCT06275035
Tata Memorial CentrePhase 3
RecruitingThe DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NCT06112639
Fondazione Don Carlo Gnocchi OnlusN/A
RecruitingCa-Mg Butyrate in GWI
NCT05367245
VA Office of Research and DevelopmentPhase 2
Enrolling By InvitationCognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
NCT06227962
Amsterdam University Medical Center
CompletedPerioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac su
NCT05279898
Beth Israel Deaconess Medical CenterN/A
UnknownIntervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection
NCT03886675
Imperial College LondonN/A
RecruitingPassive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Ribo
NCT05245903
Mclean Hospital
UnknownImpact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
NCT05363332
Corporacion Parc Tauli
CompletedAn 18-year Follow-up Study on OSA in a Population-based Cohort
NCT05077748
Chinese University of Hong Kong
RecruitingAssessing Neurocognition After Cerebrovascular Intervention
NCT03344276
University of California, San DiegoN/A
UnknownLong-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
NCT05019300
Pontificia Universidad Catolica de Chile
UnknownLong-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness
NCT04881266
University of Zurich
CompletedtDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study
NCT04925453
United States Naval Medical Center, San DiegoN/A
CompletedHyperbaric Oxygen Therapy for Post-COVID-19 Syndrome
NCT04647656
Assaf-Harofeh Medical CenterN/A
CompletedProspective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
NCT04373525
The University of Hong Kong
CompletedTransseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
NCT03946072
University of California, San FranciscoN/A
Active Not RecruitingCognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Interventi
NCT04458207
Folktandvården Stockholms län ABN/A
CompletedAdd-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia
NCT04038788
Tri-Service General HospitalN/A
Active Not RecruitingLong Term Follow up of Children Enrolled in the REDvent Study
NCT03709199
Children's Hospital Los Angeles
Active Not RecruitingCBF and NCF Changes With Brain Radiation
NCT03606421
University Health Network, Toronto
CompletedPersonalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket
NCT04005456
Metagenics, Inc.N/A
UnknownNeurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine
NCT03567304
Chiang Mai UniversityPhase 4
CompletedValidation of a German Translation and Cultural Adaptation of the Addenbrooke's Cognitive Examination III
NCT03460821
Charite University, Berlin, Germany
CompletedCathodal tDCS in MCI: A Randomized, Double-Blind, Sham-Controlled Pilot Study
NCT03521089
Mayo ClinicN/A
WithdrawnMinocycline for Alcohol Use Disorder
NCT03244592
University of California, Los AngelesPhase 1 / Phase 2
CompletedPersonal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)
NCT04007939
Metagenics, Inc.
Completed30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes
NCT03353701
University of FloridaN/A
CompletedThe Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schiz
NCT03701100
Tri-Service General HospitalN/A
CompletedEffects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
NCT03368352
University of California, San DiegoEARLY_Phase 1
TerminatedUsing Less Neurotoxic Drugs in Patients With HAND (MARAND-X)
NCT03163277
Giovanni Di PerriPhase 4
WithdrawnVitamin D Supplementation and Neurocognition
NCT03019120
Rambam Health Care CampusPhase 2
CompletedThe Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schiz
NCT03388554
Tri-Service General HospitalN/A
CompletedA Test of Neural Inertia in Humans With Xenon
NCT02768727
University of PennsylvaniaPhase 2
CompletedBiomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
NCT02992327
HealthPartners Institute
TerminatedChanges in fMRI and Neurocognitive Function in Women With Pre-eclampsia
NCT03863639
Duke University
CompletedCan Singing Kangaroo Improve Outcome of Preterm Infants
NCT03795454
University of HelsinkiN/A
WithdrawnStatin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
NCT01186289
Duke UniversityN/A